The molecular mechanisms of arsenic-induced cell transformation and apoptosis

Environmental Health Perspectives

Volumn 110, Issue SUPPL. 5, 2002, Pages 757-759

  Dong, Zigang ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

AP 1; Apoptosis; Arsenic; Cell transformation; MAP kinase; NF B; Signal transduction

Indexed keywords

ARSENIC; CARCINOGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CELL TRANSFORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE MUTATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0036804280     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.02110s5757     Document Type: Article

References (20)

1. Brachowsky A, Dudek EJ, Treadwell MD, Wetterham KE. 1996. Arsenic induced oxidant stress andNF-kappa-B activation in cultured aortic endothelial cells. Free Radic Biol Med 2:783-790.
2. Barchowsky A, Klei LR, Dudek EJ, Swartz HM, James PE. 1999. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenic. Free Radic Biol Med 27:1405-1412.
3. Bode A, Dong Z. 2000. Apoptosis induction by arsenic: mechanisms of actions and possible clinical applications for treating therapy-resistant cancers. J Drug Resist Updat 3:21-29.
4. Bode AM, Dong Z. 2002. The paradox of arsenic: molecular mechanisms of cell transformation and chemotherapeutic effects. Crit Rev Oncol/Hematol 42:5-24.
5. Chen C-J, Chuang Y-C, Lin T-M, Wu H-Y. 1985. Malignant neoplasms among residents of a Blackfoot disease-endemic-area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 45:5895-5899.
6. 4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-Raα/PML proteins. Blood 88:1052-1061.
7. 3 exerts dose-dependent dual effects on APL cells. Blood 89;3345-3353.
8. Chen N-Y, Ma W-Y, Huang C, Ding M, Dong Z. 2000a. Activation of PKC is required for arsenite-induced signal transduction. J Environ Pathol Toxicol Oncol 19(3):297-305.
9. Chen N-Y, Ma W-Y, Yang CS, Dong Z. 2000b. Inhibition of arsenite-induced apoptosis and AP-1 activity by epigallocatechin-3-gallate and theaflavins. J Environ Pathol Toxicol Oncol 19(3):287-295.
10. Forkner C, McNair-Scott TF. 1931. Arsenic asa therapeutic agent in chronic myeloid leukemia. JAMA 97:305.
11. Huang C, Bode AM, Chen N-Y, Ma W-Y, Li J, Nomura M, Dong Z. 2001. Transactivation of AP-1 in AP-1-luciferase reporter transgenic mice by arsenite and arsenate. Anticancer Res 21:261-268.
12. 2-terminal kinase-dependent, p53-independent pathway.Cancer Res 59:3053-3058.
13. Huang C, Ma W-Y, Li J, Goranson A, Dong Z, 1999b. Requirement of Erk, but not JNK, for arsenite-induced cell transformation. J Biol Chem 274:14595-14601.
14. Kandel EV, Leroy GV. 1937. Chronic arsenical poisoning during the treatment of chronic myeloid leukemia. Arch Intern Med 60:846-866.
15. Konig A, Wrazel L, Warrel RP, Jr, Rivi R, Pandolfi PP, Jakubowski A, Gabrilove JL, 1997. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood 90:562-570.
16. Meng ZQ, Meng NY. 2000. Effects of arsenic on blast transformation and DNA synthesis of human blood lymphocytes. Chemosphere 41:115-119.
17. Nriagu JO. 1994. Arsenic in the Environment, Part II. Human Health and Ecosystem Effects. New York: Wiley & Sons.
18. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto P, Duggan HM, et al. 1992. Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259-267.
19. Sommers SC, McManus RG. 1953. Multiple arsenical cancers of skin and internal organs. Cancer 6:347-359.
20. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. 1997. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 94:10907-10912.